Danaher dips on narrow revenue miss despite profit beat, raised guidance
+4.29% to $233.86 from $224.24
What moved DHR
- Adjusted earnings per share of $2.11 beat the $1.92 estimate, while revenue of $6.55 billion came in just under the $6.56 billion consensus
- The company raised full-year 2026 adjusted EPS guidance to $8.57-$8.62 from a prior $8.45-$8.60 range
- Core revenue growth excluding the respiratory product line accelerated to 5.5%, though continued respiratory headwinds weighed on sentiment
- The report comes amid a leadership transition at the company, adding to investor caution despite the earnings beat
Sources: GuruFocus · StockTitan · Investing.com · Seeking Alpha